Retroperitoneal Haematoma - Still a Medical Challenge for Abdominal Trauma.
Chirurgia (Bucur)
; 116(6): 725-736, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1650583
ABSTRACT
Introduction:
The study is presenting a personal experience of a Trauma Centre Level I and is try to conclude on optimal medical attitude for patients with retroperitoneal hematoma, still a controversial topic for traumatologists. Material andMethod:
A retrospective analysis of 22 cases of post-traumatic retroperitoneal hematoma admitted on Bucharest Emergency Hospital between September 2018 August 2021 (including time of Covid-19 pandemic), is presentedResults:
The patients (males predominance, mean age 43, mean ISS of 23), benefited of nonoperative management on admission for 10 cases (45%) with a failure rate of 4/10 due to recurrent bleeding from spleen injuries and continuous bleeding from mesenteric vessels lesions. CT scan (73% - 16 cases) within 1 hour from the admission and emergency surgery were necessary for 12 cases (55%). 2 patients benefited of angioembolization on admission. Conservative attitude for retroperitoneal hematoma was adopted for 72% cases. Over-all mortality 18% (4 patients, mean ISS of 36), among 82% polytrauma cases.Conclusions:
Algorithm of treatment is adapted to every case of retroperitoneal hematoma but the following sequences are mandatory rapid transportation to Trauma Centre Level I with medical help, correct resuscitation, immediate relevant imagistic (CT scan), emergency surgery prior to angioembolization (for hemodynamic instable patients) or after it, ICU stabilization of the patient and then definitive repair of the injuries. Despite all, mortality remains high.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Wounds, Nonpenetrating
/
COVID-19
/
Abdominal Injuries
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
Chirurgia (Bucur)
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS